Janssen drug combination extends life expectancy during trial More: Amivantamab plus lazertinib shows survival benefit in lung cancer Source: News
read moreA former Pfizer-turned-GSK scientist reportedly told colleagues that Pfizer delayed the results of its COVID-19 vaccine trials, prompting an investigation as GSK brought the matter to federal prosecutors shortly after the recent election. More: GSK tip claiming Pfizer delayed COVID
read moreThe FDA has approved Soleno Therapeutics’ Vykat XR as the first treatment for insatiable hunger related to the rare genetic condition Prader-Willi Syndrome. More: Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR Source: fierce
read moreEli Lilly is expanding its menu of direct-to-consumer healthcare offerings. The Big Pharma announced Thursday that its LillyDirect platform will now connect U.S. users to both in-person and virtual care options for Alzheimer’s disease. More: Lilly adds Alzheimer’s disease care
read moreAs part of an ongoing expansion strategy around the globe, Chiesi announced this week that it will invest 430 million euros (roughly $464 million) to build a new facility for inhalers and other health products in the Nerviano municipality of
read moreMerck & Co.’s subcutaneous formulation of Keytruda has matched up to the original intravenous version on two blood concentration measurements, paving way for a potential FDA approval that could give patients a more convenient option of the widely used cancer
read more© 1994 - 2026 B.M. Pharmaceuticals